In response to the COVID-19 emergency, many services were suspended to prioritise the treatment of patients with COVID-19. As a result, there is a growing backlog of patients requiring screening, treatment, and support, which may have long-lasting consequences for patient outcomes. Specialised Medicine conducted a series of interviews with experts in specialised healthcare to determine the impacts of COVID-19 on their specialty and the actions necessary for recovery.
This page collates written and audio interviews with experts in specialised healthcare, and will be updated with the views of additional contributors to build a comprehensive picture of the impact of COVID-19 on specialised services.
Jump to the following areas:
Impact of COVID-19 on specialised services
This article was published in the September 2020 print issue of Specialised Medicine and features interviews with the following experts in specialised healthcare:
- Dr Majid Kazmi, Chief of Cancer Services and Deputy Medical Director, Guy’s and St Thomas’ NHS Foundation Trust
- Professor Nigel Heaton, Consultant Surgeon—Hepatobiliary and Pancreatic Surgery/Liver Transplantation, King’s College Hospital
- Professor Gary Ford, Chief Executive Officer, Oxford Academic Health Science Network; Consultant Physician, Oxford University Hospitals NHS Foundation Trust; Professor of Stroke Medicine, Radcliffe Department of Medicine, University of Oxford
- Dr Frances Akor, Consultant Pharmacist—Anticoagulation, Imperial College Healthcare NHS Trust.
Please sign in to continue reading this content, or...
Register for free
Access to the Specialised Medicine website is free for UK healthcare professionals and NHS managers with a role or interest in specialised healthcare and commissioning.
Sign up now–it takes less than a minute and you’ll get unlimited access to all of our independent content, including expert articles, news, views, and specialised service resources.